| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0.7B | $0.6B | $0.6B | $0.6B | $0.6B | $0.5B | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.3B | $0.2B | $0.1B | $0.3B | $0.2B | $0.3B | $0.2B | $0.2B |
| EPS (Basic) | $1.76 | $1.34 | $0.78 | $1.84 | $1.34 | $1.66 | $1.03 | $1.14 |
| EPS (Diluted) | $1.76 | $1.34 | $0.78 | $1.84 | $1.34 | $1.66 | $0.97 | $1.08 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $89.0B | $88.8B | $87.2B | $89.5B | $93.2B | $81.5B | $69.2B | $68.7B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | — | — | — | — |
| Total Liabilities | $81.8B | $82.7B | $81.5B | $84.7B | $85.7B | $73.6B | $61.8B | $61.2B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $7.2B | $6.1B | $5.7B | $4.9B | $7.5B | $7.9B | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.1B | $1.1B | $0.9B | $1.5B | $0.6B | $0.7B | $0.7B | $1.2B |
| Investing Cash Flow | $0.7B | $-1.6B | $2.4B | $1.4B | $-11.6B | $-12.2B | $0.4B | $-2.7B |
| Capital Expenditures | $0.1B | $0.1B | $0.1B | $0.2B | $0.2B | $0.2B | $0.1B | $0.1B |
| Financing Cash Flow | $-1.8B | $0.4B | $-3.2B | $-2.8B | $11.0B | $11.3B | $1.0B | $1.6B |